The Accelerating Medicines Partnership (AMP), a 5 year collaboration to harness capabilities, scale and resources to improve efforts to develop new therapies for diseases like Alzheimer's. The focus in on research to understand diseases like AD, identify the right targets to pursue for drug therapy and accelerate the ability to bring new medicines to patients suffering from AD.